THESEUS PHARMACEUTICALS INC (THRX)
US88369M1018 - Common Stock
| Shares Outstanding | 44.65M |
| Float | 20.05M |
| Owners (insider) | 13.19% |
| Owners (institutional) | 78.1% |
| Owners (insider) change | -2.64% |
| Owners (institutional) change | -3.38% |
Insider Transactions
Top Institutional Holders
Insider Owners
| Date | Name | Type | Shares | Price | Amount |
|---|---|---|---|---|---|
| Feb 14, 2024 | ORBIMED ADVISORS LLC | Other Disposition | 17713600 | $ 0.00 | |
| Feb 14, 2024 | OrbiMed Capital GP VII LLC | Other Disposition | 17713600 | $ 0.00 | |
| Feb 14, 2024 | OrbiMed Genesis GP LLC | Other Disposition | 17713600 | $ 0.00 | |
| Feb 14, 2024 | HAYDEN DONALD J JR | Other Disposition | 10000 | $ 0.00 | |
| Feb 14, 2024 | GORDON CARL L | Other Disposition | 17713600 | $ 0.00 | |
| Feb 14, 2024 | Dukes Iain D. | Other Disposition | 388324 | $ 0.00 | |
| Feb 14, 2024 | Dahms Bradford D. | Other Disposition | 8150 | $ 0.00 | |
| Nov 6, 2023 | Shakespeare William | Option Excercise | 251084 | 0.32 | $ 80,346.88 |
| Jul 17, 2023 | ORBIMED ADVISORS LLC | Open Market Purchase | 479932 | 3.05 | $ 1,463,792.60 |
| Jul 17, 2023 | OrbiMed Genesis GP LLC | Open Market Purchase | 479932 | 3.05 | $ 1,463,792.60 |
| Jul 17, 2023 | OrbiMed Capital GP VII LLC | Open Market Purchase | 479932 | 3.05 | $ 1,463,792.60 |
| Jul 17, 2023 | GORDON CARL L | Open Market Purchase | 479932 | 3.05 | $ 1,463,792.60 |
| Jul 17, 2023 | Foresite Capital Management V, LLC | Open Market Purchase | 700000 | 2.97 | $ 2,079,000.00 |
| Jul 17, 2023 | Foresite Capital Fund V, L.P. | Open Market Purchase | 700000 | 2.97 | $ 2,079,000.00 |
| Jul 17, 2023 | Foresite Capital Opportunity Fund V, L.P. | Open Market Purchase | 700000 | 2.97 | $ 2,079,000.00 |
| Jul 17, 2023 | Foresite Capital Opportunity Management V, LLC | Open Market Purchase | 700000 | 2.97 | $ 2,079,000.00 |
| Jul 17, 2023 | Tananbaum James B. | Open Market Purchase | 700000 | 2.97 | $ 2,079,000.00 |